In vivo assays using xenograft tumor models in mice further demonstrated that reduced tumor growth and enhanced sensitivity to Tam and Abema caused by silencing of KIFC2 were partially reversed by CDK4 overexpression (Figure 6, H and I, and Supplemental Figure 13, G–I). This evidence concerns the gene CDK4 and neoplasm.